Startup Loft Orbital Is Launching AI-Powered Satellites This Fall

Building space-based AI. Designing new molecules with quantum computers. Why pink noise is bad for your sleep. All that and more in this week’s edition of The Prototype.

Novartis And Henrietta Lacks’ Family Reach A Settlement

In this week’s edition of InnovationRx, we look at the startup that wants to treat Alzheimer’s with microrobots, medical groups push back on RFK’s vaccine changes and more.

Data Center Batteries Enter The Iron Age

This week’s Current Climate newsletter also looks at how Red Texas is turning green when it comes to energy and building up U.S. supply chains for a better electric grid

The Startup Building An Operating System For Biotech AI

Building an AI infrastructure for biotech. Bacteria that munch on cancer. How to best make a cold brew. All that and more in this week’s edition of The Prototype.

This Looming Drug Development Gap Could Impact Patients’ Health

In this week’s edition of InnovationRx, we look at cheaper biologic drugs, Novo Nordisk’s $2 billion next-gen obesity drug deal, new ways of fighting cancer, and more.

You Know Who Likes Solar Power? Trump Voters

This week’s Current Climate newsletter also looks at a former top Tesla engineer’s plans to rewire the grid and the outlook for solving spiking electric power prices

Sam Altman’s Fusion Power Bet Just Got Hotter Than The Sun

Fusion power moves closer to commercialization. Storing data for 10,000 years. Why AI won’t necessarily take your job. All that and more in this week’s edition of The Prototype.

Masimo Founder Joe Kiani On The Healthtech Company’s $10 Billion Acquisition

In this week’s edition of InnovationRx, we look at Jennifer Doudna’s $1 billion plan to bring Crispr gene editing to the real world, using “boring” AI in clinics and more.

This Startup Is Boosting AI With Real Brain Cells

Training AI models using neurons. Getting hydrogen energy from water using sunlight. Elon Musk’s pivot to the Moon. All that and more in this week’s edition of the Prototype.

The FDA Refuses To Review Moderna’s Flu Vaccine

In this week’s edition of InnovationRx, we look at the healthcare giants on Forbes new Greatest Innovators list, why Garner Health is worth $1.35 billion, and more.